Effect of Tight Glycemic Control on Pancreatic Beta Cell Function in Newly Diagnosed Pediatric Type 1 Diabetes

This randomized clinical trial compares the efficacy of intensive glucose management, which included use of an automated insulin delivery system, vs standard ca

Related Keywords

United States ,Germany ,Berlin ,American ,Medtronic Minimed ,Astellas Pharma ,Roche Cobas ,Roy Beck ,Zealand Pharma ,Provention Bio ,Caladrius Biosciences ,Glooko Inc ,Ypsomed Holding ,American Diabetes Association ,Cecelia Health ,Diabetes Research Foundation ,Rd Fund ,Clver Study Group ,Bristol Myers Squibb ,Health Research ,Vertex Pharmaceuticals ,Group Information ,Drug Administration ,Startup Health ,Jaeb Center ,Medtronic ,Avotres Inc ,Novo Nordisk ,Hybrid Closed Loop Therapy ,Beta Cell Preservation ,New Onset Type ,Guardian Sensor ,Power Calculation ,Continuous Glucose Monitoring ,Ivan Name ,Interest Disclosures ,Tandem Diabetes Care ,Beta Bionics ,Bigfoot Biomedical ,Abata Therapeutics ,Medtronic Diabetes ,Juvenile Diabetes Research Foundation ,Abbott Diabetes ,Isla Technologies ,Maicell Therapeutics ,Nimbus Therapeutics ,American Diabetes ,Capillary Biomedical ,Tandem Diabetes ,Farmaceutici Spa ,Study Group ,International Conference ,Advanced Technologies ,